Archit Organosys Limited - chemicals and materials in Ahmadabad City, Gujarat, India. FY 2026 financials and compliance.
CIN L24110GJ1993PLC019941 Incorporated 04 August 1993 ROC Ahmedabad HQ Ahmadabad City, Gujarat, India
Active Listed - BSE: 524640 Public Limited Company chemicals and materials
Data last updated
Revenue · FY 2026
₹140.95 Cr
▲ 12.22% YoY
Computed EBITDA · FY 2026
₹19.3 Cr
▲ 20.14% YoY
Net profit · FY 2026
₹8.03 Cr
▲ 59.02% YoY
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹20.52 Cr
Issued & subscribed
Open charges
₹93.63 Cr
Satisfied ₹7.35 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
36
Latest available

About Archit Organosys Limited

Data last updated: 15 July 2026

Archit Organosys Limited is a public limited company based in Ahmadabad City, Gujarat, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 04 August 1993, the company has been in operation for over 33 years.

Registered with ROC Ahmedabad under CIN L24110GJ1993PLC019941. Listed on BSE: 524640.

Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹20.52 Cr. Formerly known as Shri Chlochem Limited. It is led by directors including Nikul Jagdishchandra Patel and Archana Kandarp Amin.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Ahmadabad City, Gujarat.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹140.95 Cr, a growth of 12.22% compared to the previous year. The net worth stands at ₹76.23 Cr (up 10.15% YoY). Total assets are valued at ₹126.67 Cr (up 3.05% YoY).

The company has a workforce of approximately 36 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Archit Organosys. As per MCA filings, the company has open charges of ₹93.63 Cr and satisfied charges of ₹7.35 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website architorg.com.

Company Details of Archit Organosys Limited
CIN L24110GJ1993PLC019941
Registration Number 019941
Incorporation Date 04 August 1993
ROC Ahmedabad
Listing Status Listed (BSE: 524640)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    903 9Th Floor Venus Benecia Near Pakwan Restaurant, Bodakdev S. G. Highway, Ahmadabad City, Gujarat, India – 380054
  • Industry
    Chemicals and Materials, Industrial Chemicals
Company report
Archit Organosys Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Archit Organosys Limited report

Financials, compliance, directors, charges, ownership and filings for Archit Organosys Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Archit Organosys Limited

Archit Organosys Limited operates one associated brand: Archit Organosys. These brands represent Archit Organosys Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufacturer and suppliers of monochloro acetic acids for laboratory use architorg.com

Competitors & Alternatives of Archit Organosys Limited

Brands and companies operating in the same space as Archit Organosys Limited include Abcam, Meridian Bioscience, Stem Cell Technologies and 6 more.

Competitor Description Location Founded
Abcam Abcam Biological reagents and antibodies are developed for life science research. Cambridge, United Kingdom, United Kingdom 1998
Meridian Bioscience Meridian Bioscience Molecular diagnostic device and kits Ohio, United States, United States 1976
Stem Cell Technologies Stem Cell Technologies Developer of cell culture media and ancillary reagents for life science research Vancouver, Canada, Canada 1993
BBI Solutions BBI Solutions Kits and reagents are developed for life science research applications. Crumlin, United Kingdom, United Kingdom 1986
Cayman Chem Cayman Chem Bioreagents and assay kits are developed, with preclinical services provided. Ann Arbor, United States, United States 1980
PL BioScience PL BioScience Cell culture solutions for stem cell expansion are provided. Aachen, Germany, Germany 2015
Teknova Teknova Molecular biology reagents and kits are supplied for research applications. Hollister, United States, United States 1996
BioChain BioChain Provider of products and services for clinical diagnosis, genomics, and proteomics Hayward, United States, United States 1994
Sangon Biotech Sangon Biotech Research services, reagents, and kits for biotech applications are provided. Shanghai, China, China 2003

Business Activity of Archit Organosys Limited

Archit Organosys Limited is engaged in multiple principal business activities such as manufacturing, trade, and professional, scientific and technical, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, retail trading, other professional, scientific and technical activities. The company has 3 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
G Trade G2 Retail Trading Locked
M Professional, Scientific and Technical M9 Other professional, scientific and technical activities Locked
Premium access

Business activity turnover details for Archit Organosys Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Archit Organosys Limited

Archit Organosys Limited is audited by M/s. G K Choksi & Co. (ICAI peer reviewed, certificate valid till 2029-01-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s. G K Choksi & Co. (ICAI peer reviewed, certificate valid till 2029-01-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Archit Organosys Limited

Archit Organosys Limited is currently managed by 7 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Nikul Jagdishchandra Patel Director 05 Aug 2021 4 Years 11 Months Current
Archana Kandarp Amin Whole-Time Director 01 Apr 2009 17 Years 3 Months Current
Kandarp Krishnakant Amin Whole-Time Director 22 Jan 2000 26 Years 5 Months Current
Archit Kandarpbhai Amin Whole-Time Director 12 May 2017 9 Years 2 Months Current
Shreeraj Vikram Desai Director 13 Feb 2020 6 Years 5 Months Current
Bhavin Gautamkumar Shah Director 26 Jun 2023 3 Years 0 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Archit Organosys Limited FY 2026 filings available

Archit Organosys Limited reported revenue of ₹140.95 Cr (up 12.22% YoY) for FY 2026.

Revenue · FY 2026
₹140.95 Cr ▲ 12.22%
Profit · FY 2026
₹8.03 Cr ▲ 59.02%
Computed EBITDA · FY 2026
₹19.3 Cr ▲ 20.14%
Revenue₹ Cr · Standalone050100150FY 2019: ₹85 Cr84.7FY 2019FY 2020: ₹77 Cr · -9.4% YoY76.7-9.4%FY 2020FY 2021: ₹95 Cr · +23.2% YoY94.5+23.2%FY 2021FY 2022: ₹137 Cr · +44.6% YoY137+44.6%FY 2022FY 2023: ₹128 Cr · -6.5% YoY128-6.5%FY 2023FY 2024: ₹113 Cr · -11.4% YoY113-11.4%FY 2024FY 2025: ₹126 Cr · +11% YoY126+11%FY 2025FY 2026: ₹141 Cr · +12.2% YoY141+12.2%FY 2026
Net Profit₹ Cr · Standalone-5051015FY 2019: ₹5 Cr (loss)-4.7FY 2019FY 2020: ₹1 Cr (loss) · +83% YoY-0.8FY 2020FY 2021: ₹5 Cr · +725% YoY5+725%FY 2021FY 2022: ₹8 Cr · +64.4% YoY8.2+64.4%FY 2022FY 2023: ₹11 Cr · +38.8% YoY11.4+38.8%FY 2023FY 2024: ₹3 Cr · -70.8% YoY3.3-70.8%FY 2024FY 2025: ₹5 Cr · +51.3% YoY5.1+51.3%FY 2025FY 2026: ₹8 Cr · +59% YoY8+59%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0204060Q1'25: ₹27 Cr27Q1'25Q2'25: ₹30 Cr29.5Q2'25Q3'25: ₹26 Cr25.9Q3'25Q4'25: ₹43 Cr43.2Q4'25Q1'26: ₹33 Cr · +22.9% YoY33.2+22.9%Q1'26Q2'26: ₹33 Cr · +11.2% YoY32.9+11.2%Q2'26Q3'26: ₹38 Cr · +48.4% YoY38.4+48.4%Q3'26Q4'26: ₹36 Cr · -15.5% YoY36.5-15.5%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹140.95 Cr ₹125.6 Cr ₹113.19 Cr ₹127.78 Cr ₹136.66 Cr ₹94.51 Cr ₹76.69 Cr ₹84.67 Cr
Other Income ₹2.88 Cr ₹3.09 Cr ₹2.51 Cr ₹1.92 Cr ₹1.92 Cr ₹54.32 Lakh ₹2.29 Cr ₹3.38 Cr
Total Income ₹143.84 Cr ₹128.69 Cr ₹115.7 Cr ₹129.71 Cr ₹138.58 Cr ₹95.05 Cr ₹78.98 Cr ₹88.05 Cr
Cost of Materials Consumed ₹34.07 Cr ₹37.47 Cr ₹34.47 Cr ₹39.24 Cr ₹54.06 Cr ₹30.63 Cr ₹27.78 Cr ₹33.18 Cr
Purchases of Stock-in-Trade ₹62.96 Cr ₹48.53 Cr ₹43.94 Cr ₹37.2 Cr ₹41.72 Cr ₹30.89 Cr ₹24.08 Cr ₹37.95 Cr
Changes in Inventories ₹1.38 Cr -₹1.06 Cr -₹15.95 Lakh ₹65.02 Lakh -₹18.45 Lakh -₹41.13 Lakh ₹1.85 Cr -₹36.96 Lakh
Employee Benefit Expense ₹7.37 Cr ₹7.1 Cr ₹8.14 Cr ₹7.37 Cr ₹6.51 Cr ₹6.1 Cr ₹6.17 Cr ₹5.36 Cr
Finance Costs ₹2.29 Cr ₹2.58 Cr ₹2.58 Cr ₹2.21 Cr ₹2.44 Cr ₹3.25 Cr ₹3.15 Cr ₹3.59 Cr
Depreciation & Amortisation ₹6.01 Cr ₹5.94 Cr ₹5.66 Cr ₹4.83 Cr ₹4.69 Cr ₹3.67 Cr ₹3.47 Cr ₹2.79 Cr
Other Expenses ₹18.76 Cr ₹20.59 Cr ₹20.05 Cr ₹24.42 Cr ₹17.93 Cr ₹16.25 Cr ₹13.27 Cr ₹11.81 Cr
Total Expenses ₹132.84 Cr ₹121.15 Cr ₹114.68 Cr ₹115.92 Cr ₹127.16 Cr ₹90.37 Cr ₹79.77 Cr ₹94.3 Cr
Profit Before Exceptional Items & Tax ₹10.99 Cr ₹7.54 Cr ₹1.01 Cr ₹13.79 Cr ₹11.43 Cr ₹4.68 Cr -₹79.12 Lakh -₹6.26 Cr
Exceptional Items ₹0 ₹0 ₹3.37 Cr ₹1.65 Cr ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹10.99 Cr ₹7.54 Cr ₹4.39 Cr ₹15.44 Cr ₹11.43 Cr ₹4.68 Cr -₹79.12 Lakh -₹6.26 Cr
Total Tax Expense ₹2.96 Cr ₹2.49 Cr ₹1.05 Cr ₹4.01 Cr ₹3.19 Cr -₹32.24 Lakh ₹99,000 -₹1.54 Cr
Net Profit ₹8.03 Cr ₹5.05 Cr ₹3.34 Cr ₹11.43 Cr ₹8.23 Cr ₹5.01 Cr -₹80.11 Lakh -₹4.72 Cr
Other Comprehensive Income ₹2.06 Lakh ₹83,000 -₹1.92 Lakh ₹7.3 Lakh ₹2.38 Lakh ₹4.91 Lakh -₹1.35 Lakh ₹4.22 Lakh
Total Comprehensive Income ₹8.05 Cr ₹5.06 Cr ₹3.32 Cr ₹11.5 Cr ₹8.26 Cr ₹5.06 Cr -₹81.46 Lakh -₹4.67 Cr
EBITDA (computed) ₹19.3 Cr ₹16.06 Cr ₹9.25 Cr ₹20.83 Cr ₹18.55 Cr ₹11.59 Cr ₹5.84 Cr ₹12.42 Lakh
Basic EPS ₹3.91 ₹2.46 ₹1.63 ₹5.57 ₹4.01 ₹3.33 ₹-0.53 ₹-3.14
Diluted EPS ₹3.91 ₹2.46 ₹1.63 ₹5.57 ₹4.24 ₹3.33 ₹-0.53 ₹-3.14
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹126.67 Cr ₹122.92 Cr ₹108.24 Cr ₹122.48 Cr ₹103.55 Cr ₹87.49 Cr ₹83.17 Cr ₹84.11 Cr
Non-current Assets ₹65.75 Cr ₹61.42 Cr ₹66.75 Cr ₹69.36 Cr ₹60.63 Cr ₹53.37 Cr ₹52.9 Cr ₹53.33 Cr
Current Assets ₹60.92 Cr ₹61.5 Cr ₹41.49 Cr ₹52.95 Cr ₹42.87 Cr ₹34.11 Cr ₹30.27 Cr ₹30.78 Cr
Property, Plant & Equipment ₹49.85 Cr ₹53.39 Cr ₹58.89 Cr ₹50.43 Cr ₹45.05 Cr ₹47.67 Cr ₹50.4 Cr ₹46.97 Cr
Inventories ₹2.95 Cr ₹4.3 Cr ₹3.44 Cr ₹3.38 Cr ₹5.94 Cr ₹3.54 Cr ₹3.28 Cr ₹5.84 Cr
Trade Receivables ₹24.55 Cr ₹23.05 Cr ₹22.23 Cr ₹37.36 Cr ₹27.35 Cr ₹25 Cr ₹19.72 Cr ₹14.35 Cr
Cash & Equivalents ₹1.37 Cr ₹6.81 Lakh ₹3.82 Cr ₹5.12 Cr ₹5.35 Cr ₹3.81 Cr ₹2.95 Cr ₹4.9 Cr
Equity (Net Worth) ₹76.23 Cr ₹69.21 Cr ₹64.15 Cr ₹61.85 Cr ₹51.89 Cr ₹40.54 Cr ₹34.11 Cr ₹34.92 Cr
Equity Share Capital ₹20.52 Cr ₹20.52 Cr ₹20.52 Cr ₹20.52 Cr ₹20.52 Cr ₹15.02 Cr ₹15.02 Cr ₹15.02 Cr
Borrowings (Non-current) ₹2.81 Cr ₹4.49 Cr ₹7.63 Cr ₹14.2 Cr ₹12.21 Cr ₹12.11 Cr ₹12.4 Cr ₹17.73 Cr
Borrowings (Current) ₹21.86 Cr ₹22.46 Cr ₹18.03 Cr ₹16.75 Cr ₹19.91 Cr ₹9.58 Cr ₹14.3 Cr ₹13.66 Cr
Total Debt (computed) ₹24.66 Cr ₹26.95 Cr ₹25.66 Cr ₹30.95 Cr ₹32.12 Cr ₹21.7 Cr ₹26.7 Cr ₹31.4 Cr
Current Liabilities ₹43.22 Cr ₹45.7 Cr ₹34.26 Cr ₹44.13 Cr ₹37.6 Cr ₹34.28 Cr ₹35.58 Cr ₹31.26 Cr
Total Liabilities ₹50.44 Cr ₹53.71 Cr ₹44.09 Cr ₹60.62 Cr ₹51.66 Cr ₹46.95 Cr ₹49.06 Cr ₹49.19 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹2.68 Cr ₹18.52 Cr ₹10.2 Cr ₹16.9 Cr ₹10.62 Cr
Investing Cash Flow ₹4.39 Cr -₹20.85 Cr -₹2.26 Cr -₹10.98 Cr -₹11.52 Cr
Financing Cash Flow -₹5.77 Cr -₹1.43 Cr -₹9.13 Cr -₹6.14 Cr ₹2.43 Cr
Capital Expenditure ₹1.24 Cr ₹49.76 Lakh ₹1.61 Cr ₹13.19 Cr ₹10.84 Cr
Free Cash Flow (computed) ₹1.44 Cr ₹18.02 Cr ₹8.58 Cr ₹3.71 Cr -₹21.77 Lakh
Dividends Paid ₹1.03 Cr ₹5,000 ₹98.51 Lakh ₹1.54 Cr ₹1.03 Cr
Net Change in Cash ₹1.31 Cr -₹3.75 Cr -₹1.2 Cr -₹22.92 Lakh ₹1.54 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹36.5 Cr ₹38.4 Cr ₹32.86 Cr ₹33.2 Cr ₹43.18 Cr ₹25.87 Cr ₹29.54 Cr ₹27 Cr
Other Income -₹47.01 Lakh ₹90.24 Lakh ₹1.46 Cr ₹99.53 Lakh ₹1.06 Cr ₹93.37 Lakh ₹62.9 Lakh ₹46.59 Lakh
Total Income ₹36.03 Cr ₹39.3 Cr ₹34.32 Cr ₹34.19 Cr ₹44.25 Cr ₹26.8 Cr ₹30.17 Cr ₹27.47 Cr
Cost of Materials Consumed ₹1.94 Cr ₹14.85 Cr ₹9.9 Cr ₹6.83 Cr ₹11.51 Cr ₹7.36 Cr ₹7.88 Cr ₹10.71 Cr
Purchases of Stock-in-Trade ₹22.43 Cr ₹13.17 Cr ₹14.07 Cr ₹13.29 Cr ₹20.91 Cr ₹8.04 Cr ₹12.5 Cr ₹7.08 Cr
Changes in Inventories -₹14.03 Lakh -₹3.08 Lakh -₹33.01 Lakh ₹1.88 Cr -₹1.82 Cr ₹44.32 Lakh ₹69.12 Lakh -₹37.55 Lakh
Employee Benefit Expense ₹1.83 Cr ₹1.81 Cr ₹1.94 Cr ₹1.79 Cr ₹1.86 Cr ₹2.16 Cr ₹2.48 Cr ₹1.96 Cr
Finance Costs ₹46.2 Lakh ₹55.56 Lakh ₹67.4 Lakh ₹59.66 Lakh ₹71.15 Lakh ₹47.18 Lakh ₹78.07 Lakh ₹61.58 Lakh
Depreciation & Amortisation ₹1.49 Cr ₹1.52 Cr ₹1.52 Cr ₹1.49 Cr ₹1.46 Cr ₹1.49 Cr ₹1.5 Cr ₹1.49 Cr
Other Expenses ₹5.55 Cr ₹3.91 Cr ₹4.58 Cr ₹5.27 Cr ₹6.31 Cr ₹5.21 Cr ₹3.14 Cr ₹4.58 Cr
Total Expenses ₹33.56 Cr ₹35.79 Cr ₹32.35 Cr ₹31.14 Cr ₹40.94 Cr ₹25.18 Cr ₹28.97 Cr ₹26.06 Cr
Profit Before Exceptional Items & Tax ₹2.47 Cr ₹3.51 Cr ₹1.97 Cr ₹3.05 Cr ₹3.31 Cr ₹1.63 Cr ₹1.2 Cr ₹1.41 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹2.47 Cr ₹3.51 Cr ₹1.97 Cr ₹3.05 Cr ₹3.31 Cr ₹1.63 Cr ₹1.2 Cr ₹1.41 Cr
Total Tax Expense ₹44.51 Lakh ₹1.07 Cr ₹43.17 Lakh ₹1.01 Cr ₹1.29 Cr ₹61.36 Lakh ₹18 Lakh ₹40.54 Lakh
Net Profit ₹2.02 Cr ₹2.43 Cr ₹1.54 Cr ₹2.04 Cr ₹2.02 Cr ₹1.01 Cr ₹1.02 Cr ₹1.01 Cr
Other Comprehensive Income ₹3.01 Lakh -₹95,000 ₹0 ₹0 ₹83,000 ₹0 ₹0 ₹0
Total Comprehensive Income ₹2.05 Cr ₹2.43 Cr ₹1.54 Cr ₹2.04 Cr ₹2.03 Cr ₹1.01 Cr ₹1.02 Cr ₹1.01 Cr
EBITDA (computed) ₹4.42 Cr ₹5.58 Cr ₹4.16 Cr ₹5.13 Cr ₹5.48 Cr ₹3.59 Cr ₹3.48 Cr ₹3.51 Cr
Basic EPS ₹0.99 ₹1.19 ₹0.75 ₹0.99 ₹0.98 ₹0.49 ₹0.50 ₹0.49
Diluted EPS ₹0.99 ₹1.19 ₹0.75 ₹0.99 ₹0.98 ₹0.49 ₹0.50 ₹0.49
Latest 8 quarters shown.
Metrics FY 2024 FY 2023
Revenue from Operations ₹113.19 Cr ₹127.78 Cr
Other Income ₹2.44 Cr ₹1.86 Cr
Total Income ₹115.64 Cr ₹129.64 Cr
Cost of Materials Consumed ₹34.47 Cr ₹39.24 Cr
Purchases of Stock-in-Trade ₹43.94 Cr ₹37.2 Cr
Changes in Inventories -₹15.95 Lakh ₹65.02 Lakh
Employee Benefit Expense ₹8.14 Cr ₹7.37 Cr
Finance Costs ₹2.58 Cr ₹2.21 Cr
Depreciation & Amortisation ₹5.66 Cr ₹4.83 Cr
Other Expenses ₹20.05 Cr ₹24.43 Cr
Total Expenses ₹114.68 Cr ₹115.94 Cr
Profit Before Exceptional Items & Tax ₹95.16 Lakh ₹13.71 Cr
Exceptional Items ₹3.37 Cr ₹1.65 Cr
Profit Before Tax ₹4.32 Cr ₹15.36 Cr
Total Tax Expense ₹1.05 Cr ₹4.01 Cr
Net Profit ₹3.28 Cr ₹11.35 Cr
  attributable to Owners ₹3.28 Cr -
  attributable to NCI ₹0 -
Other Comprehensive Income -₹1.92 Lakh ₹7.3 Lakh
Total Comprehensive Income ₹3.26 Cr ₹11.42 Cr
EBITDA (computed) ₹9.19 Cr ₹20.75 Cr
Basic EPS ₹1.60 ₹5.53
Diluted EPS ₹1.60 ₹5.53
Metrics FY 2024 FY 2023
Total Assets ₹108.24 Cr ₹122.43 Cr
Non-current Assets ₹66.75 Cr ₹72.23 Cr
Current Assets ₹41.49 Cr ₹50.04 Cr
Property, Plant & Equipment ₹58.89 Cr ₹50.43 Cr
Inventories ₹3.44 Cr ₹3.38 Cr
Trade Receivables ₹22.23 Cr ₹37.36 Cr
Cash & Equivalents ₹3.82 Cr ₹5.13 Cr
Equity (Net Worth) ₹64.15 Cr ₹61.78 Cr
Equity Share Capital ₹20.52 Cr ₹20.52 Cr
Borrowings (Non-current) ₹7.63 Cr ₹14.2 Cr
Borrowings (Current) ₹18.03 Cr ₹16.75 Cr
Total Debt (computed) ₹25.66 Cr ₹30.95 Cr
Current Liabilities ₹34.26 Cr ₹44.16 Cr
Total Liabilities ₹44.09 Cr ₹60.66 Cr
Metrics FY 2024 FY 2023
Operating Cash Flow ₹10.1 Cr ₹19.43 Cr
Investing Cash Flow -₹2.16 Cr -₹13.61 Cr
Financing Cash Flow -₹9.13 Cr -₹6.04 Cr
Capital Expenditure ₹1.8 Cr ₹15.82 Cr
Free Cash Flow (computed) ₹8.3 Cr ₹3.61 Cr
Dividends Paid ₹98.51 Lakh ₹1.54 Cr
Net Change in Cash -₹1.19 Cr -₹22.4 Lakh
Want more history and ratios?
You're viewing the latest exchange-filed financials for Archit Organosys Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Archit Organosys Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 65.88%, retail and other public shareholders hold 34.12% of Archit Organosys Limited. The company had 9,446 shareholders on record.

Promoters: 65.88%Retail & Others: 34.12%
Mar 2026
QUARTER
65.88% Promoters
34.12% Retail & Others
Promoter holding - history
Now 65.88% · Mar 2026High 65.88% · Mar 2026Low 62.37% · Jun 2023
61%62.5%64%65.5%67%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 62.37%Sep 2023: 62.37%Dec 2023: 62.37%Mar 2024: 63.26%Jun 2024: 64.65%Sep 2024: 64.65%Dec 2024: 64.84%Mar 2025: 65.30%Jun 2025: 65.39%Sep 2025: 65.39%Dec 2025: 65.86%Mar 2026: 65.88%62.37%65.88%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters65.88%65.86%65.39%65.39%65.30%64.84%
Public34.12%34.14%34.61%34.61%34.70%35.16%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters65.88%65.30%63.26%
Public34.12%34.70%36.74%
Promoter change (YoY, %pts)+0.58+2.04-

Group Structure of Archit Organosys Limited

Archit Organosys Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Archit Organosys Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Archit Life Science Limited U24290GJ2022PLC135184 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Archit Organosys Limited

Open charges
₹93.63 Cr
Satisfied charges
₹7.35 Cr
Breakdown by lending institutions
Others₹93.63 Cr
Latest charge details
DateLenderAmountStatus
25 Mar 2004 Others ₹37.03 Cr Open
13 Jan 2004 Others ₹56.6 Cr Open
24 Feb 2023 Others ₹3.1 Cr Satisfied
26 Mar 2015 Icici Bank Limited ₹25 Lakh Satisfied
26 Jun 2004 Union Bank of India ₹1.6 Cr Satisfied

Total charge records: 9 View all charges

Employees and EPFO Compliance at Archit Organosys Limited

Archit Organosys Limited has a workforce of 36 employees as of Apr 06, 2024.

Employee count
36
Active EPFO establishments
2
Employee growth
-14.29%
Premium access

Employee and EPFO history for Archit Organosys Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Archit Organosys Limited

Premium access

GST registrations and filing compliance for Archit Organosys Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Archit Organosys Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Archit Organosys Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Archit Organosys Limited

Premium access

MSME payment history for Archit Organosys Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Archit Organosys Limited

Premium access

Corporate group structure for Archit Organosys Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Archit Organosys Limited

Premium access

MCA filings and documents for Archit Organosys Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Archit Organosys Limited

Charges
10 Jun 2026
A charge with Others of Rs. 37.03 Cr registered on 25 Mar 2004 with Charge ID 90099808 was modified on 10 Jun 2026.
Charges
02 May 2026
A charge with Others of Rs. 56.60 Cr registered on 13 Jan 2004 with Charge ID 90096878 was modified on 02 May 2026.
Activity
29 Sep 2025
Archit Organosys Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Directors
25 Aug 2025
Chirag Chouhan was appointed as a Company Secretary on 25 Aug 2025 & has been associated with this company since 10 months 26 days.
Directors
21 Jul 2025
Anilkumar Ganeshbhai Patel was appointed as a Cfo on 21 Jul 2025 & has been associated with this company since 1 year.
Charges
14 Jul 2025
A charge registered on 24 Feb 2023 via Charge ID 100690656 with Others was fully satisfied on 14 Jul 2025.

Recent News on Archit Organosys Limited

Frequently Asked Questions about Archit Organosys Limited

Archit Organosys Limited is an active public limited company in the chemicals and materials sector based in Ahmadabad City, Gujarat, India. It was incorporated on 04 August 1993 (33+ years old) and is registered under CIN L24110GJ1993PLC019941. Listed on BSE: 524640. The company has 36 employees.

Archit Organosys Limited reported revenue of ₹140.95 Cr for FY 2026 (up 12.22% YoY) based on standalone BSE filings.

The current directors of Archit Organosys Limited are:

The primary industry of Archit Organosys Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.

Yes. Archit Organosys Limited is listed on BSE with code 524640.

Archit Organosys Limited can be reached at the registered office: 903 9Th Floor Venus Benecia Near Pakwan Restaurant, Bodakdev S. G. Highway, Ahmadabad City, Gujarat, India – 380054, or through the website architorg.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available